H
Hemetron provides an at‑home blood testing device that quantitatively measures C‑reactive protein levels within minutes. Users collect a small drop of blood, run the test, and view results on a smartphone app without needing to ship samples. The solution enables continuous inflammation monitoring to support more precise treatment decisions.
Updated 4 months ago
Funding
$50K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Hemetron offers an at-home blood testing solution that allows users to collect a small blood sample and receive quantitative results for C-reactive protein levels within 10 minutes, all without the need for sample shipping. This technology enables individuals to monitor inflammation levels conveniently, facilitating better treatment optimization by healthcare providers.